Antiviral Drugs Market Report By Market Data Forecast 2024


Posted May 21, 2019 by sandycool

Antiviral Drugs Market By Application - (HIV/AIDS, Hepatitis, Herpes, Influenza, And Others)
 
Recent Developments

Hoffmann-La Roche AG is a healthcare company that operates under two divisions: Pharmaceuticals and Diagnostics. Hoffmann-La Roche is active in the field pharmaceuticals for cancer treatment, against virus diseases and for treatment of metabolic diseases. Xofluza was approved based on results from the phase 3 CAPSTONE-1 study of a single-dose of Xofluza associated with placebo or Tamiflu (oseltamivir) 75 mg, twice daily for five days, in otherwise healthy people with the flu, as well as events from a placebo-controlled phase 2 study in otherwise healthy people with the flu. Xofluza significantly reduced the duration of flu symptoms related to placebo and demonstrated similar efficacy compared to oseltamivir. Analysts say the new treatment will have to produce more evidence of significant gains in these high-risk groups in order for healthcare systems to turn away from generic oseltamivir.
To know more read: https://www.marketdataforecast.com/market-reports/global-antiviral-drugs-market-1587/

Market Segmentations

Market Data Forecast published a report named Antiviral Drugs Market. It is valued around USD 41.31 billion by 2023 from USD 32.21 billion in 2018, growing at a CAGR of 5.10% during the forecast period 2018-2023.

Report is segmented by
Application
·         HIV/AIDS,
·         Hepatitis,
·         Herpes,
·         Influenza.
End-Users

Hospitals,
Research Institutes,
Laboratory Centers.
Based on the application, HIV/AIDS plays the key role in the market. On the bases of end-user, hospitals are estimated to have largest growth in the market.

Geographical Segmentation:

Based on the geography the market is analyzed under several regions namely, North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is estimated to command the major market share of 34.0% in the global antiviral drugs market. 

Key market players in the market are –

Johnson & Johnson (USA),
Novartis International AG (Switzerland),
Roche Holding AG (Switzerland),
Pfizer (USA),
Merck and Co. Inc (USA).
View sample and decide: https://www.marketdataforecast.com/market-reports/global-antiviral-drugs-market-1587/request-sample

Scope of the report:

The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

Contact Info:  
Name: Mr. Abhishek Shukla
Email: [email protected]
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Data Forecast
Phone 8887029626
Business Address 2nd Floor, Lakeview Plaza, Kavuri Hills
Hyderabad
Country India
Categories Advertising , Health
Tags analysis , antiviral drugs , forecast , growth
Last Updated May 21, 2019